Your browser doesn't support javascript.
The Impact of the SARS-Cov2 Pandemic on a Persuasive Educational Antimicrobial Stewardship Program in a University Hospital in Southern Italy: A Pre-Post Study.
Macera, Margherita; Onorato, Lorenzo; Calò, Federica; Monari, Caterina; Annibale, Rosa; Signoriello, Giuseppe; Donnarumma, Giovanna; Montemurro, Maria Vittoria; Galdiero, Massimiliano; Coppola, Nicola.
  • Macera M; Department of Mental Health and Public Medicine, Section of Infectious Diseases, University of Campania Luigi Vanvitelli, 80138 Naples, Italy.
  • Onorato L; Department of Mental Health and Public Medicine, Section of Infectious Diseases, University of Campania Luigi Vanvitelli, 80138 Naples, Italy.
  • Calò F; Department of Mental Health and Public Medicine, Section of Infectious Diseases, University of Campania Luigi Vanvitelli, 80138 Naples, Italy.
  • Monari C; Department of Mental Health and Public Medicine, Section of Infectious Diseases, University of Campania Luigi Vanvitelli, 80138 Naples, Italy.
  • Annibale R; Pharmacy Unit, AOU Vanvitelli, 80138 Naples, Italy.
  • Signoriello G; Department of Mental Health and Public Medicine-Medical Statistics Unit, University of Campania Luigi Vanvitelli, 80138 Naples, Italy.
  • Donnarumma G; Department of Experimental Medicine, University of Campania Luigi Vanvitelli, 80138 Naples, Italy.
  • Montemurro MV; Direzione Sanitaria, AOU Vanvitelli, 80138 Naples, Italy.
  • Galdiero M; Department of Experimental Medicine, University of Campania Luigi Vanvitelli, 80138 Naples, Italy.
  • Coppola N; Department of Mental Health and Public Medicine, Section of Infectious Diseases, University of Campania Luigi Vanvitelli, 80138 Naples, Italy.
Antibiotics (Basel) ; 10(11)2021 Nov 16.
Article in English | MEDLINE | ID: covidwho-1523844
ABSTRACT

OBJECTIVES:

We evaluated the effect of the pandemic on the disruption of a persuasive educational antimicrobial stewardship program (ASP) conducted in a university hospital in southern Italy.

METHODS:

In March 2020, the ASP, which began in January 2017 and was carried out at different times in 10 wards, was stopped due to the COVID-19 pandemic. We conducted an observational study with interrupted time series analysis to compare the antibiotic consumption and costs, average length of hospital stay and in-hospital mortality between 12 months before and 9 months after the interruption.

RESULTS:

Four medical, four surgical wards and two ICUs were included in the study, for a total of 35,921 patient days. Among the medical wards we observed after the interruption a significant increase in fluoroquinolone use, with a change in trend (CT) of 0.996, p = 0.027. In the surgical wards, we observed a significant increase in the overall consumption, with a change in level (CL) of 24.4, p = 0.005, and in the use of third and fourth generation cephalosporins (CL 4.7, p = 0.003). In two ICUs, we observed a significant increase in piperacillin/tazobactam and fluoroquinolone consumption (CT 9.28, p = 0.019, and 2.4, p = 0.047). In the wards with a duration of ASP less than 30 months, we observed a significant increase in antibiotic consumption in the use of piperacillin/tazobactam and fluoroquinolones (CT 12.9, p = 0.022 4.12, p = 0.029; 1.004, p = 0.011).

CONCLUSIONS:

The interruption of ASP during COVID-19 led to an increase in the consumption of broad-spectrum antibiotics, particularly in surgical wards and in those with a duration of ASP less than 30 months.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Observational study / Prognostic study Language: English Year: 2021 Document Type: Article Affiliation country: Antibiotics10111405

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Observational study / Prognostic study Language: English Year: 2021 Document Type: Article Affiliation country: Antibiotics10111405